TRLS vs. FDBK, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COG
Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry.
Trellus Health vs. Its Competitors
Feedback (LON:FDBK) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.
In the previous week, Feedback had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for Feedback and 0 mentions for Trellus Health. Feedback's average media sentiment score of 1.36 beat Trellus Health's score of 0.00 indicating that Feedback is being referred to more favorably in the media.
Trellus Health has lower revenue, but higher earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.
Feedback has a net margin of -279.16% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat Feedback's return on equity.
Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500.
36.6% of Feedback shares are owned by institutional investors. Comparatively, 5.8% of Trellus Health shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Comparatively, 21.5% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Feedback beats Trellus Health on 7 of the 13 factors compared between the two stocks.
Get Trellus Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TRLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trellus Health Competitors List
Related Companies and Tools
This page (LON:TRLS) was last updated on 10/17/2025 by MarketBeat.com Staff
